MA1C26245; Thermo Scientific), KU-MEL-1 (ref

MA1C26245; Thermo Scientific), KU-MEL-1 (ref. proteins TRP1, TRP2, tyrosinase, gp100, Melan-A and KU-MEL-1. The sensitivity of our Metiamide recombinant bacteria-based approach was validated with a CD4 T cell clone with known antigen specificity. The ability of each of the 107 clones to secrete cytokines upon nonspecific stimulation was verified. Results None of the 107 T cell clones was Metiamide able to secrete tumor necrosis factor-, interferon-, interleukin (IL)-5, or IL-17 upon contact with autologous B cells loaded with any of the six common melanocytic proteins. Nine clones secreted high-level IL-17 upon stimulation with beads coated with antibodies. Conclusions The self-antigens that triggered the VKH disease in this patient Metiamide probably derive from proteins other than the six melanocytic proteins mentioned above. Further study of antigens that are recognized by potential autoreactive T cells from VKH patients is likely to benefit from testing a broader set of melanocytic proteins. Introduction Vogt-Koyanagi-Harada (VKH) disease is characterized by an inaugural uveomeningitidis and hearing loss, followed at a later stage by depigmentation of eyes and skin [1]. An association between VKH disease and human leukocyte antigen (HLA)-DR4 was described for Asian, Hispanic, or Native American patients [2-4], and in particular the HLA-DRB1*04:05 subtype was associated with VKH in Asian and Brazilian patients [5-8]. The DRB1 molecules associated with VKH disease share the motif LLEQRRA67C73 located in the peptide-binding cleft [9-11]. The HLA molecules sharing this motif may thus present to T cells a common set of peptides and by this contribute to the recognition of the ocular self-peptides [9]. VKH pathogenesis remains incompletely understood, but autoimmune T cells have nonetheless been implicated. Activated CD4 T lymphocytes are present in the cerebrospinal fluid (CSF) of VKH patients [12], usually in higher numbers than their CD8 counterparts. Interferon (IFN)- was found elevated Mouse monoclonal to EphB3 in the aqueous humor of VKH patients with uveitis [13]. A few differences between blood T cells from VKH patients and control donors have been reported: a decreased expression of CD18 and AKNA transcription factors in VKH patients [14], a higher expression of transcription factor T-bet [15], and less apoptosis of T cells from VKH patients after in vitro stimulation with phytohemagglutinin [16]. Upon ex vivo nonspecific stimulation, blood CD4 T lymphocytes of VKH patients secreted slightly more IFN- and interleukin (IL)-2 than did cells obtained from control individuals, whereas IL-4 secretion was similar in both groups [17]. IL-17 production by CD4 T cells was stimulated by IL-23, which was suggested to be responsible for the development of uveitis seen in patients with VKH disease, and IL-17-producing CD4 T cells of VKH patients were shown to produce proinflammatory cytokines, such as tumor necrosis factor (TNF)- [18,19]. Melanocytes can be found in the four affected tissues: choroid, inner ear, leptomeninges, and skin [20-22], and accordingly the melanocytes were proposed as the source of self-antigens. Noteworthy, skin melanocytes are destroyed (vitiligo) by some cancer patients recovering from their melanoma [23]. A patient with a metastatic melanoma developed late manifestations of VKH disease after adoptive transfer of tumor-infiltrating lymphocytes containing a high proportion of CD8 T cells specific for a peptide from melanocytic protein Metiamide Melan-A [24]. In rats, injection of melanocytic proteins tyrosinase-related protein-1 (TRP1) and TRP2 induced ocular and extra-ocular inflammation, similar to human VKH disease [25]. T lymphocytes are predominant among the leucocytes present in the CSF of VKH patients, but monocytes are also present. Some of them contain melanin granules [26,27], presumably following phagocytosis of damaged melanocytes from the meninges, suggesting that melanocyte-derived antigens can activate the CSF T lymphocytes. Viruses have been proposed to be responsible for the destruction of melanocytes, thus initiating VKH disease [28]. CD4 T lymphocytes isolated from the blood or the aqueous humor of DRB1*04:05 VKH patients could be stimulated Metiamide in vitro with peptides derived from melanocytic proteins TRP1, TRP2, tyrosinase, and gp100. The expanded T lymphocytes produced IFN- upon further stimulation with the same peptides [29-32]. Antibodies against the melanocytic protein KU-MEL-1.